CalciMedica Q1 net loss $19.3M ($23.43/sh); cash $34.2M; Nasdaq delisted

CalciMedica, Inc.

2023-Q1 EPS reported -$23.43

Net loss $19.3M ($23.43 diluted EPS); operating expenses $22.3M incl. $16.2M one-time Graybug merger costs.
Cash, equivalents and short-term investments $34.2M as of March 31; expects runway into H2 2024.
CARPO Phase 2b trial: IDMC reviewed first 90 pts, recommended continue; expects topline Q1 2024.
Stock suspended from Nasdaq March 30; now trading on OTCQB, working to relist.
Merger with Graybug closed March 20; CalciMedica equityholders own ~72%, Graybug ~28%.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

CalciMedica, Inc. reported first quarter ended March 31, 2023 results: net income Net loss was $19.3 million, or $23.43 per share (basic and diluted), for the three months ended March 31, 2023., EPS $23.43 per share (basic and diluted).

Period: first quarter ended March 31, 2023
Net income: Net loss was $19.3 million, or $23.43 per share (basic and diluted), for the three months ended March 31, 2023.
EPS: $23.43 per share (basic and diluted)
Result: reported results

Exact text from the filing

Financial Results for the Three Months Ended March 31, 2023: • Cash, Cash Equivalents and Marketable Securities: As of March 31, 2023, CalciMedica had $34.2 million in cash, cash equivalents and short-term investments. • Total Operating Expenses: Total operating expenses were $22.3 million, which included $16.2 million of one-time charges related to accelerated vesting and severance for employees of Graybug Vision, Inc. (Graybug) at the time of the merger with Graybug. • Net Loss: Net loss was $19.3 million, or $23.43 per share (basic and diluted), for the three months ended March 31, 2023.

View on SEC.gov

168 earnings releases filed in the last 30 days. Browse all earnings releases →

CalciMedica, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-144226

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.